Maen Hussein
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- CAR-T cell therapy research
- Pancreatic and Hepatic Oncology Research
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 40
- Cancer Immunotherapy and Biomarkers 25
- Lung Cancer Research Studies 16
- CAR-T cell therapy research 5
- Colorectal Cancer Treatments and Studies 4
- Pancreatic and Hepatic Oncology Research 4
-
- Lung Cancer Treatments and Mutations 19
- Renal cell carcinoma treatment 6
- Co-authors
- Henry Jacob Conter (6 shared papers)Federico Cappuzzo (7 shared papers)Alan Sandler (3 shared papers)Niels Reinmuth (8 shared papers)Marcin Kowanetz (4 shared papers)Michael McCleod (6 shared papers)Davey B. Daniel (6 shared papers)Hans‐Georg Kopp (3 shared papers)
- Journals
- Journal of Clinical Oncology (17 papers)Journal of Thoracic Oncology (9 papers)Annals of Oncology (5 papers)Lung Cancer (2 papers)The Lancet Oncology (2 papers)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Maen Hussein
44 papers receiving 2.8k citations
Maen Hussein's Hit Papers
Peers
Comparison fields: 5 of 75
- Oncology 2.5k
- Pulmonary and Respiratory Medicine 1.7k
- Immunology 642
- Cancer Research 224
- Pathology and Forensic Medicine 82
Countries citing papers authored by Maen Hussein
This map shows the geographic impact of Maen Hussein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maen Hussein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maen Hussein more than expected).
Fields of papers citing papers by Maen Hussein
This network shows the impact of papers produced by Maen Hussein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maen Hussein. The network helps show where Maen Hussein may publish in the future.
Co-authors
The 25 scholars most cited alongside Maen Hussein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial Hit paper breakdown → | 2019 | 1137 |
| 2 | Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial Hit paper breakdown → | 2020 | 405 |
| 3 | Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study Hit paper breakdown → | 2022 | 296 |
| 4 | Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non–Small-Cell Lung Cancer: The Phase III POSEIDON Study Hit paper breakdown → | 2022 | 238 |
| 5 | 2020 | 191 | |
| 6 | 2018 | 170 | |
| 7 | 2020 | 82 | |
| 8 | 2017 | 76 | |
| 9 | 2018 | 46 | |
| 10 | 2017 | 39 | |
| 11 | 2021 | 19 | |
| 12 | 2021 | 16 | |
| 13 | 2023 | 15 | |
| 14 | 2019 | 15 | |
| 15 | 2015 | 14 | |
| 16 | 2017 | 12 | |
| 17 | 2020 | 11 | |
| 18 | 2005 | 11 | |
| 19 | 2019 | 9 | |
| 20 | 2023 | 8 |
About Maen Hussein
Maen Hussein is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Epidemiology, having authored 46 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (25 papers), Lung Cancer Treatments and Mutations (19 papers), Lung Cancer Research Studies (16 papers), Renal cell carcinoma treatment (6 papers), Cancer Genomics and Diagnostics (6 papers), CAR-T cell therapy research (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). The work is most often cited by research in Oncology (2.5k citations), Pulmonary and Respiratory Medicine (1.7k citations), Immunology (642 citations), Cancer Research (224 citations) and Pathology and Forensic Medicine (82 citations). Maen Hussein has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Henry Jacob Conter, Federico Cappuzzo, Alan Sandler, Niels Reinmuth, Marcin Kowanetz, Michael McCleod, Davey B. Daniel, Hans‐Georg Kopp, Howard West and Tarek Mekhail. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Annals of Oncology, Lung Cancer and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.